Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taxon Therapeutics
Tiburon, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Taxon Therapeutics was an early-stage biotechnology company focused on leveraging the human microbiome to develop novel therapeutics for oncology and infectious diseases. The company aimed to identify specific microbial consortia and metabolites that could modulate the immune system or directly inhibit pathogen growth. Despite its initial focus on high-impact clinical areas, the company ceased operations before advancing programs into significant clinical trials. Its legacy is primarily associated with the broader movement of microbiome-based drug discovery in the early 2010s.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Taxon Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taxon Therapeutics.